US Penny Stocks: 908 Devices Leads This Trio

In This Article:

As the U.S. stock market responds to recent election results with significant gains across major indices, investors are exploring diverse opportunities within this evolving landscape. Penny stocks, a term that might seem outdated, continue to hold relevance for those seeking affordable entry points and potential growth in smaller or emerging companies. In light of current market conditions, we examine three penny stocks that stand out for their financial resilience and potential appeal to investors looking beyond traditional large-cap investments.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

BAB (OTCPK:BABB)

$0.7995

$5.81M

★★★★★★

RLX Technology (NYSE:RLX)

$1.61

$2.06B

★★★★★★

LexinFintech Holdings (NasdaqGS:LX)

$3.58

$603.4M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$170.21M

★★★★★★

Commercial Vehicle Group (NasdaqGS:CVGI)

$2.40

$99.68M

★★★★☆☆

Flexible Solutions International (NYSEAM:FSI)

$4.04

$50.42M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$69.71M

★★★★★★

Permianville Royalty Trust (NYSE:PVL)

$1.56

$51.48M

★★★★★★

PHX Minerals (NYSE:PHX)

$3.46

$128.99M

★★★★★☆

CBAK Energy Technology (NasdaqCM:CBAT)

$1.12

$99.38M

★★★★★☆

Click here to see the full list of 755 stocks from our US Penny Stocks screener.

Let's take a closer look at a couple of our picks from the screened companies.

908 Devices

Simply Wall St Financial Health Rating: ★★★★★★

Overview: 908 Devices Inc. is a commercial-stage technology company that offers handheld and desktop mass spectrometry devices for analyzing unknown materials in fields such as life sciences research, bioprocessing, pharma/biopharma, and forensics, with a market cap of approximately $115.75 million.

Operations: The company generates its revenue from the Scientific & Technical Instruments segment, amounting to $52.69 million.

Market Cap: $115.75M

908 Devices Inc., with a market cap of approximately US$115.75 million, is debt-free and has a seasoned management team. Despite being unprofitable, it shows revenue growth potential, forecasting an annual increase of 19.31%. The company reported second-quarter revenue of US$14.05 million, up from US$12.09 million the previous year, although net losses widened to US$12.55 million from US$9.35 million. Short-term assets significantly exceed liabilities, providing financial stability for operations over the next few years without additional funding needs despite shareholder dilution over the past year by 7.2%.

Waiting for permission
Allow microphone access to enable voice search

Try again.